Relationship between red blood cell distribution width and intermediate-term mortality in elderly patients after percutaneous coronary intervention

Journal of Geriatric Cardiology

Volumn 12, Issue 1, 2015, Pages 17-22

  Liu, Xin Min ^a   Ma, Chang Sheng ^a   Liu, Xiao Hui ^a   Du, Xin ^a   Kang, Jun Ping ^a   Zhang, Yin ^a   Wu, Jia Hui ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Coronary artery disease; Elderly patients; Percutaneous coronary intervention; Red blood cell distribution width

Indexed keywords

CHOLESTEROL; GLUCOSE; HEMOGLOBIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CELLULAR DISTRIBUTION; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ERYTHROCYTE; FEMALE; FOLLOW UP; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREOPERATIVE PERIOD; PROGNOSIS; RED BLOOD CELL DISTRIBUTION WIDTH; SURGICAL MORTALITY; TREATMENT INDICATION;

EID: 84920935606     PISSN: 16715411     EISSN: None     Source Type: Journal    
DOI: 10.11909/j.issn.1671-5411.2015.01.013     Document Type: Article

References (40)

1. TIME Investigators. Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary artery disease (TIME): a randomized trial. Lancet 2001; 358: 951-957.
2. Graham MM, Ghali WA, Faris PD, et al. Survival after coronary revascularization in the elderly. Circulation 2002; 105: 2378-2384.
3. Singh M, Peterson ED, Roe MT, et al. Trends in the association between age and in-hospital mortality after percutaneous coronary intervention: National Cardiovascular Data Registry experience. Circ Cardiovasc Interv 2009; 2: 20-26.
4. Bauer T, Koeth O, Jünger C, et al. Effect of an invasive strategy on in-hospital outcome in elderly patients with non-STelevation myocardial infarction. Eur Heart J 2007; 28: 2873.
5. Newell MC, Henry JT, Henry TD, et al. Impact of age on treatment and outcomes in ST elevation myocardial infarction. Am Heart J 2011; 161: 664-672.
6. Batchelor WB, Anstrom KJ, Muhlbaier LH, et al. Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: results in 7,472 octogenarians. National Cardiovascular Network Collaboration. J Am Coll Cardiol 2000; 36: 723-730.
7. Felker G M, Allen L A, Pocock S J, et al. Red blood cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol 2007; 50: 40-47.
8. Pascual-Figal DA, Bonaque JC, Redondo B, et al. Red blood cell distribution width predicts long-term outcome regardless of anaemia status in acute heart failure patients. Eur J Heart Fail 2009; 11: 840-846.
9. Tonelli M, Sacks F, Arnold M, et al. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation 2008; 117: 163-168.
10. Dabbah S, Hammerman H, Markiewicz W, et al. Relation between red cell distribution width and clinical outcomes after acute myocardial infarction. Am J Cardiol 2010; 105: 312-317.
11. Nabais S, Losa N, Gaspar A, et al. Association between red blood cell distribution width and outcomes at six months in patients with acute coronary syndromes. Rev Port Cardoil 2009; 28: 905-924.
12. Rhodes CJ, Wharton J, Howard LS, et al. Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension. Heart 2011; 97: 1054-1060.
13. Hampole CV, Mehrotra AK, Thenappan T, et al. Usefulness of red cell distribution width as a prognostic marker in pulmonary hypertension. Am J Cardiol 2009; 104: 868-872.
14. Osadnik T, Strzelczyk J, Hawranek M, et al. Red cell distribution width is associated with long-term prognosis in patients with stable coronary artery disease. BMC Cardiovasc Disord 2013; 13: 113.
15. Tsuboi S, Miyauchi K, Kasai T, et al. Impact of red blood cell distribution width on long-term mortality in diabetic patients after percutaneous coronary intervention. Circ J 2013; 77: 456-461.
16. Mathew V, Frye RL, Lennon R, et al. Comparison of survival after successful percutaneous coronary intervention of patients with diabetes mellitus receiving insulin versus those receiving only diet and/or oral hypoglycemic agents. Am J Cardiol 2004; 93: 399-403.
17. Beohar N, Davidson CJ, Kip KE, et al. Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA 2007; 297: 1992-2000.
18. Caixeta A, Leon MB, Lansky AJ, et al. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents. J Am Coll Cardiol 2009; 54: 894-902.
19. Hosseini SK, Ansari MJ, Lotfi Tokaldany M, et al. Association between preprocedural hemoglobin level and 1-year outcome of elective percutaneous coronary intervention. J Cardiovasc Med 2014; 15: 331-335.
20. Mathew V, Frye RL, Lennon R, et al. Comparison of survival after successful percutaneous coronary intervention of patients with diabetes mellitus receiving insulin versus those receiving only diet and/or oral hypoglycemic agents. Am J Cardiol 2004; 93: 399-403.
21. Beohar N, Davidson CJ, Kip KE, et al. Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA 2007; 297: 1992-2000.
22. Caixeta A, Leon MB, Lansky AJ, et al. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents. J Am Coll Cardiol 2009; 54: 894-902.
23. Bental T, Assali A, Vaknin-Assa H, et al. A comparative analysis of major clinical outcomes using drug-eluting stents versus bare-metal stents in a large consecutive patient cohort. Catheter Cardiovasc Interv 2010; 76: 374-380.
24. Serebruany V, Pokov I, Kuliczkowski W, et al. Baseline platelet activity and response after clopidogrel in 257 diabetics among 822 patients with coronary artery disease. Thromb Haemost 2008; 100: 76-82.
25. Machecourt J, Danchin N, Lablanche JM, et al. Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT matched-cohort registry. J Am Coll Cardiol 2007; 50: 501-508.
26. Mauri L, O'Malley AJ, Cutlip DE, et al. Effects of stent length and lesion length on coronary restenosis. Am J Cardiol 2004; 93: 1340-1346.
27. De Boer SP, Roos-Hesselink JW, van Leeuwen MA, et al. Excess mortality in women compared to men after PCI in STEMI: An analysis of 11,931 patients during 2000-2009. Int J Cardiol 2014; 176: 456-463.
28. Milcent C, Dormont B, Durand-Zaleski I, et al. Gender differences in hospital mortality and use of percutaneous coronary intervention in acute myocardial infarction: microsimulation analysis of the1999 nationwide French hospitals database. Circulation 2007; 115: 833-839.
29. Benamer H, Tafflet M, Bataille S, et al. Female gender is an independent predictor of in-hospital mortality after STEMI in the era of primary PCI: insights from the greater paris area PCI registry. Eurointervention 2011; 6: 1073-1079.
30. Park DW, Kim YH, Yun SC, et al. Sex difference in clinical outcomes after percutaneous coronary intervention in Korean population. Am Heart J 2014; 167: 743-752.
31. Lichtman JH, Wang Y, Jones SB. Age and sex differences in in hospital complication rates and mortality after percutaneous coronary intervention procedures: evidence from the NCDR. Am Heart J 2014; 167: 376-383.
32. Patel KV, Ferrucci L, Ershler WB, et al. Red blood cell distribution width and the risk of death in middle-aged and older adults. Arch Intern Med 2009; 169: 515-523.
33. Lippi G, Targher G, Montagnana M, et al. Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med 2009; 133: 628-632.
34. Ma FL, Li S, Li XL, et al. Correlation of red cell distribution width with the severity of coronary artery disease: a large Chinese cohort study from a single center. Chin Med J (Engl) 2013; 126: 1053-1057.
35. Veeranna V, Zalawadiya SK, Panaich S, et al. Comparative analysis of red cell distribution width and high sensitivity C-reactive protein for coronary artery disease mortality prediction in multi-ethnic population: Findings from the 1999-2004 NHANES. Int J Cardiol 2013; 168: 5156-5161.
36. Isik T, Kurt M, Ayhan E, et al. Relation of red cell distribution width with presence and severity of coronary artery ectasia. Clin Appl Thromb Hemost 2012; 18: 441-447.
37. Akin F, Köse N, Ayca B, et al. Relation between red cell distribution width and severity of coronary artery disease in patients with acute myocardial infarction. Angiology 2013; 64: 592-596.
38. Allen LA, Felker Gm, Mehra MR, et al. Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure. J Card Fail 2010; 16: 230-238.
39. Lee P, Peng H, Gellbart T, et al. Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc Natl Acad Sci USA 2005; 102: 1906-1910.
40. Schieffer B, Schieffer E, Hilfiker-Kleiner D, et al. Expression of angiotensin I and interleukin 6 in human coronary atherosclerotic plaques:potential implications for inflammation and plaque instablility. Circulation 2000; 101: 1372-1378.